Skip to main content


Post Doctoral Research Associate in the laboratory of Prof. Andrea Brancale.

I am working on a multidisciplinary project to develop innovative antiviral compounds against the dengue virus. This project is funded by Marie Skłodowska Curie Actions (Individual Fellowships).


Giulio Nannetti is currently a Postdoctoral Research Associate in the School of Pharmacy and Pharmaceutical Sciences of Cardiff University.

In 2010, he received a Master’s degree in Medical Biotechnologies at the University of Siena (Italy). After that, he moved to the University of Padua (Italy) to join the laboratory of Prof. A. Loregian and Prof. G. Palù for a PhD in Biomedicine.  While in this position, he was mainly involved in a project focused on the development of anti-influenza compounds targeting the protein-protein interactions of the viral polymerase subunits. After concluding his PhD studies in 2014, he conducted some follow-up research at the University of Padua as a Postdoctoral Research Associate. In 2018, he was awarded a Marie Skłodowska-Curie Individual Fellowship and he joined the laboratory of Prof. A. Brancale at Cardiff University to carry out a project which aims to develop new antiviral drugs for the treatment of dengue virus infection.










My research interests have always been focused in the area of virology and antiviral drug discovery.

I am currently involved in a multidisciplinary project to develop innovative antiviral compounds against the dengue virus, a mosquito-borne viral pathogen that can cause a severe and potentially fatal disease in humans. This project, entitled “FINDER”, has recently been funded by the European Commission within the Marie Skłodowska-Curie Actions (MSC-IF 2017, grant no. 798105). FINDER aims to develop anti-dengue inhibitors able to disrupt protein-protein interactions between viral proteins, which are essential for the virus life cycle. This research is carried out at the School of Pharmacy and Pharmaceutical Sciences at Cardiff University under the supervision of Prof. Andrea Brancale, in partnership with the lab of Prof. Arianna Loregian at the University of Padua (Italy). To know more about this research, please visit the FINDER blog here.

Previously, I was involved in a variety of antiviral drug discovery researches, in particular in projects to identify anti-influenza inhibitors that act by disrupting subunit interactions of the viral polymerase. In addition, I also developed some new analytical methods for the quantification of antimicrobial drugs in samples of human plasma.

You can find out more about me and my previous research studies here.